Awaken-Bio

Awaken Bio develops next-generation 3D in-vitro assays designed to mimic brain biomechanics. This technology aims to facilitate accelerated, breakthrough drug discovery by providing high patient transferability and faster turnaround times to identify clinically relevant therapeutics for neurodegenerative diseases. The company operates as a research-focused entity within the biotechnology sector.

By focusing on the complex biomechanical environment of the brain, the company's platform provides researchers and pharmaceutical partners with tools to improve the predictability of preclinical drug testing. This approach is intended to bridge the gap between initial laboratory studies and clinical applications, helping to mitigate the challenges of traditional drug screening processes in the field of neurology.